Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet Ital ; 60(1)2024 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-38989625

RESUMO

Staphylococcus aureus, Escherichia coli and Mycoplasma bovis are the most commonly isolated mastitis pathogens. The aim of this study was to evaluate the efficacy of a new mixed vaccine against mastitis caused by  Staphylococcus aureus, Escherichia coli, and Mycoplasma bovis. For this purpose, a mixed inactivated vaccine was administered subcutaneously to 24 heifers as one dose (2 mL) on the 45th day before birth and the second dose 21 days later. In 9 heifers, 2 mL of PBS was administered as placebo instead of vaccine. Then, heifers were divided into 3 groups as 7 vaccinated and 3 unvaccinated animals. Staphylococcus aureus, Escherichia coli, and Mycoplasma bovis were administered to the groups through intramammary route. Three vaccinated heifers were considered the common control without bacteria in all groups. The parameters considered to assess the effect of vaccination were clinical findings, bacterial count in milk, somatic cell count, and antibody titers. Clinical signs were observed only in the unvaccinated placebo group. Bacteria count and somatic cell count in milk increased in vaccinated and unvaccinated heifers. However, this increase was less in vaccinated animals and gradually returned to the normal level. In the unvaccinated heifers, it was ever high. Serum antibody titers were measured before and after vaccination. Antibody titers were high in vaccinated heifers after vaccination and were negative in unvaccinated heifers. In conclusion, the mixed vaccine had beneficial effect against Staphylococcus aureus, Escherichia coli, and Mycoplasma bovis mastitis and stimulated the immune response of vaccinated heifers.


Assuntos
Escherichia coli , Mastite Bovina , Infecções por Mycoplasma , Mycoplasma bovis , Infecções Estafilocócicas , Staphylococcus aureus , Vacinas de Produtos Inativados , Animais , Bovinos , Mycoplasma bovis/imunologia , Feminino , Mastite Bovina/prevenção & controle , Mastite Bovina/microbiologia , Mastite Bovina/imunologia , Staphylococcus aureus/imunologia , Infecções por Mycoplasma/veterinária , Infecções por Mycoplasma/prevenção & controle , Vacinas de Produtos Inativados/imunologia , Infecções Estafilocócicas/prevenção & controle , Infecções Estafilocócicas/veterinária , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/administração & dosagem , Infecções por Escherichia coli/prevenção & controle , Infecções por Escherichia coli/veterinária , Infecções por Escherichia coli/imunologia
2.
Food Addit Contam Part B Surveill ; 17(2): 122-128, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38424740

RESUMO

This study was conducted to provide data on the amount of acrylamide (AA) in 270 heat-treated carbohydrate-rich foods in Turkey, determined by gas chromatography-mass spectrometry (GC-MS). A total of 270 samples were analysed and it was found that 85% of potato chips, 80% of biscuits, 85% of cakes, 80% of bread, 80% of roasted peanuts, 80% of roasted nuts and 85% of pretzels contained AA above the limit of quantification (LOQ). Analytical results indicated that 10 corn chips samples, 4 biscuits samples, all bread samples, all wheat bread samples, 2 dried bread samples and 1 pretzel sample contained AA levels above the benchmark levels of 150, 350, 50, 50, 300 and 300 µg/kg, respectively, as set by the European Commission.


Assuntos
Acrilamida , Contaminação de Alimentos , Cromatografia Gasosa-Espectrometria de Massas , Temperatura Alta , Acrilamida/análise , Acrilamida/química , Turquia , Contaminação de Alimentos/análise , Humanos , Culinária/métodos , Pão/análise , Limite de Detecção , Manipulação de Alimentos/métodos , Carboidratos da Dieta/análise , Solanum tuberosum/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...